Moderna, Inc.

Moderna Misses on EPS, Stock Down 0.24%

Moderna reported a larger-than-expected loss per share, which may raise concerns among investors about its financial health. The stock reacted slightly down by 0.24%, indicating a muted response to the earnings report. Without guidance or additional commentary from management, investors may be left uncertain about the company's future direction.